Literature DB >> 29746007

Preterm growth restriction and bronchopulmonary dysplasia: the vascular hypothesis and related physiology.

Arvind Sehgal1,2, Stella M Gwini3, Samuel Menahem4, Beth J Allison5,6, Suzanne L Miller5,6, Graeme R Polglase5,6.   

Abstract

KEY POINTS: Approximately 5-10% pregnancies are affected by fetal growth restriction. Preterm infants affected by fetal growth restriction have a higher incidence of bronchopulmonary dysplasia. The present study is the first to measure pulmonary artery thickness and stiffness. The findings show that impaired vasculogenesis may be a contributory factor in the higher incidence of bronchopulmonary dysplasia in preterm growth restricted infants. The study addresses the mechanistic link between fetal programming and vascular architecture and mechanics. ABSTRACT: Bronchopulmonary dysplasia is the most common respiratory sequelae of prematurity and histopathologically features fewer, dysmorphic pulmonary arteries. The present study aimed to characterize pulmonary artery mechanics and cardiac function in preterm infants with fetal growth restriction (FGR) compared to those appropriate for gestational age (AGA) in the early neonatal period. This prospective study reviewed 40 preterm infants between 28 to 32 weeks gestational age (GA). Twenty infants had a birthweight <10th centile and were compared with 20 preterm AGA infants. A single high resolution echocardiogram was performed to measure right pulmonary arterial and right ventricular (RV) indices. The GA and birthweight of FGR and AGA infants were 29.8 ± 1.3 vs. 30 ± 0.9 weeks (P = 0.78) and 923.4 g ± 168 vs. 1403 g ± 237 (P < 0.001), respectively. Assessments were made at 10.5 ± 1.3 days after birth. The FGR infants had significantly thicker right pulmonary artery inferior wall (843.5 ± 68 vs. 761 ± 40 μm, P < 0.001) with reduced pulsatility (51.6 ± 7.6 μm vs. 59.7 ± 7.5 μm, P = 0.001). The RV contractility [fractional area change (28.7 ± 3.8% vs 32.5 ± 3.1%, P = 0.001), tricuspid annular peak systolic excursion (TAPSE) (5.2 ± 0.3% vs. 5.9 ± 0.7%, P = 0.0002) and myocardial performance index (0.35 ± 0.03 vs. 0.28 ± 0.02, P < 0.001)] was significantly impaired in FGR infants. Significant correlation between RV longitudinal contractility (TAPSE) and time to peak velocity/RV ejection time (measure of RV afterload) was noted (r2  =  0.5, P < 0.001). Altered pulmonary vascular mechanics and cardiac performance reflect maladaptive changes in response to utero-placental insufficiency. Whether managing pulmonary vascular disease will alter clinical outcomes remains to be studied prospectively.
© 2018 The Authors. The Journal of Physiology © 2018 The Physiological Society.

Entities:  

Keywords:  angiogenesis; bronchopulmonary dysplasia; echocardiography; fetal growth restriction; pulmonary vasculature; right ventricle

Year:  2018        PMID: 29746007      PMCID: PMC6376075          DOI: 10.1113/JP276040

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  9 in total

1.  Overview: pulmonary vascular function in health and disease.

Authors:  Larissa A Shimoda
Journal:  J Physiol       Date:  2019-02       Impact factor: 5.182

2.  Extracellular Signal-Regulated Kinase 1 Alone Is Dispensable for Hyperoxia-Mediated Alveolar and Pulmonary Vascular Simplification in Neonatal Mice.

Authors:  Renuka T Menon; Shyam Thapa; Amrit Kumar Shrestha; Roberto Barrios; Binoy Shivanna
Journal:  Antioxidants (Basel)       Date:  2022-06-08

Review 3.  Intrauterine Hypoxia and Epigenetic Programming in Lung Development and Disease.

Authors:  Yajie Tong; Shuqing Zhang; Suzette Riddle; Lubo Zhang; Rui Song; Dongmei Yue
Journal:  Biomedicines       Date:  2021-08-02

4.  Increased risk of pulmonary hypertension following premature birth.

Authors:  Estelle Naumburg; Lars Söderström
Journal:  BMC Pediatr       Date:  2019-08-17       Impact factor: 2.125

5.  Respiratory distress syndrome and bronchopulmonary dysplasia after fetal growth restriction: Lessons from a natural experiment in identical twins.

Authors:  Sophie G Groene; Jip A Spekman; Arjan B Te Pas; Bastiaan T Heijmans; Monique C Haak; Jeanine M M van Klink; Arno A W Roest; Enrico Lopriore
Journal:  EClinicalMedicine       Date:  2021-01-29

6.  Prognostic Role of Biomarkers for Pulmonary Arterial Hypertension Associated with Bronchopulmonary Dysplasia in Extremely Premature Infants.

Authors:  Chun Chen; Bingchun Lin; Meiqi Wang; Chuanzhong Yang
Journal:  Appl Bionics Biomech       Date:  2022-01-28       Impact factor: 1.781

7.  Risk factors that affect the degree of bronchopulmonary dysplasia in very preterm infants: a 5-year retrospective study.

Authors:  Tingting Yang; Qianqian Shen; Siyu Wang; Tianfang Dong; Liang Liang; Fan Xu; Youfang He; Chunlei Li; Fang Luo; Jiahong Liang; Chunhui Tang; Jinghui Yang
Journal:  BMC Pediatr       Date:  2022-04-12       Impact factor: 2.125

8.  Is Umbilical Cord Blood Therapy an Effective Treatment for Early Lung Injury in Growth Restriction?

Authors:  Beth J Allison; Hannah Youn; Atul Malhotra; Courtney A McDonald; Margie Castillo-Melendez; Yen Pham; Amy E Sutherland; Graham Jenkin; Graeme R Polglase; Suzanne L Miller
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-03       Impact factor: 5.555

9.  Assessing pulmonary circulation in severe bronchopulmonary dysplasia using functional echocardiography.

Authors:  Arvind Sehgal; Douglas Blank; Calum T Roberts; Samuel Menahem; Stuart B Hooper
Journal:  Physiol Rep       Date:  2021-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.